No, the guide, the below what we would have expected is absolutely driven by what we saw on 1Q. I think if you just step back and look at the products. Just as a reminder, stop loss, we're going to every year we get to practice a lot underwriting and see what the experiences look like, the market, the competition in the market, all those things will put pressure on where the loss ratio ends up in the future. As we sit here today, obviously, great first quarter, we'll see how the rest of the year plays itself out. We feel good about the foundation of it. But there's nothing there that says okay, now we shouldn't think about for stop loss, in particular 77 bn to 80 bn, our long term view. That's just where we would continue to think about it at. In the life and disability world, and obviously, as a reminder, again, we don't keep the disability risk, we reinsure the bulk of that, from a life perspective again, I'd give you a similar answer. 77 to 80 is sort of what we think of as the right long term answer. First quarter, as we've experienced here, a bit on the higher end of that, or above 80. But typical of a more normalized life, mortality environment. Maybe typical is not exactly the right word. But as we think about the long term forward view, again, we still think where we play 77 to 80 makes sense, a little bit more nuanced on the supplemental health side of things, voluntary products, again, have performed well for us over the last handful of years. We've done a really good job maturing and growing that business. And continue to think that we will put upward momentum to the loss ratio, just as cases come up to renewal given that good experience, you'd expect there to be competition there. And then things that we're trying to do from a customer value perspective from a claims and claims integration process and trying to improve that and just make the usage of those benefits easier, simpler, for the end consumer is a big part of where we want to just continue to improve what we're doing in market and the value that those products provide. But yes, to come back to where you started. 1Q is going to be a driver as we think about the full year view, and then would expect it to revert back into the range that we established.